Sara Secall

Sara Secall is a Partner and the Director of Investments in Life Sciences at Inveready Technology Investment Group. She holds an undergraduate degree in chemistry, a Master of Science in environmental science, and a Master of Business Administration. Prior to her current executive position, she supported various technology and life sciences companies as both an investor and a strategic consultant. At Inveready, she oversees venture capital allocations across multiple verticals, contributing to a portfolio that includes Másmóvil, which achieved a valuation exceeding 1 billion to become the first unicorn in Spain. Her strategic oversight helped the firm liquidate its initial fund with a 100 million return and secure a multiplier greater than 5x within the life sciences sector. Secall currently focuses on driving continuous innovation and financial growth across dynamic digital technology and biotechnology markets.